Excelerate Energy (EE) Appoints Tyler D. Todd to its Board

Excelerate Energy, Inc. (NYSE: EE) today announced the election of Tyler D. Todd to its Board of Directors, effective October 10, 2024. Henry G. Kleemeier has retired from the Board effective October 9, 2024. Mr. Todd will serve on the Compensation and Nominating and Corporate Governance Committees.

Mr. Todd currently serves as Senior Vice President of Business Development at Kaiser-Francis Oil Company, an upstream oil and gas company owned by George Kaiser, Excelerate Energy’s controlling stockholder, which he joined in 2014. Prior to joining Kaiser-Francis Oil Company, Mr. Todd worked at WPX Energy, Inc. where he held various petroleum engineering roles. Mr. Todd currently serves as a director of Endeavor Natural Gas III (a Kaiser-controlled entity) and as a member of the industry advisory board for the Mewbourne School of Petroleum & Geological Engineering at the University of Oklahoma. Mr. Todd earned a bachelor’s degree from the University of Oklahoma and a master’s degree in business administration from Harvard University.

“We are very pleased that Tyler Todd has agreed to join the Excelerate Board,” said Steven Kobos, President and Chief Executive Officer of Excelerate. “He brings a wealth of operational, technical and strategic planning experience to the Board and we look forward to working with him as the Company continues to expand its presence in both new and existing markets around the world.

“In addition, on behalf of our entire Board, we thank Henry “Buddy” Kleemeier for his important contributions to Excelerate Energy during his time as a Board member. Buddy has been more than a director. For many years, I have regarded Buddy as a paragon of leadership, a mentor and a friend. His keen insights have always made him a valuable sounding board for me and the Excelerate team. We appreciate his service and wish him the best.”

You May Also Be Interested In

• Freedom Broker Starts CarGurus Inc. (CARG) at Buy
• Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
• Aspire Biopharma to acquire automotive supplier for $30 million